We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Chemicon and Axordia to Co-Develop Antibody Markers

News   Oct 03, 2005

 
Chemicon and Axordia to Co-Develop Antibody Markers
 
 
 

RELATED ARTICLES

Existing Drug Could Treat Porphyria

News

An existing antifungal drug, ciclopirox (CPX), has been shown to improve symptoms associated with congenital erythropoietic porphyria – the rarest type of porphyria.

READ MORE

Gene Editing Makes Mice Cocaine-Proof

News

A new paper has taken a ingenious route towards treating cocaine addicted mice – by developing a CRISPR-powered skin grafts that produce an anti-cocaine enzyme.

READ MORE

Allergy Driver Influences Brain Cell Communication

News

The chemotactic protein CCL17 attracts immune cells to where they are needed. Now scientists have discovered a completely new function: CCL17 also influences signal transmission in the brain.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE